APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Contraceptive Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Contraceptive Drugs Industry Growth and Trends Forecast to 2032

Report ID 174019710120 December 2025108 pages

Choose your research edition.

Industry ResearchOral Contraceptive Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contraceptive Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Oral Contraceptive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contraceptive Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contraceptive Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contraceptive Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Contraceptive Drugs include Teva Pharmaceutical, Johnson & Johnson, Baijingyu, Merck, Pfizer, Bayer, ZiZhu, Novo Nordisk A/S and Huazhong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Contraceptive Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Contraceptive Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Contraceptive Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Contraceptive Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Contraceptive Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Contraceptive Drugs Market by Company

Teva Pharmaceutical

Johnson & Johnson

Baijingyu

Merck

Pfizer

Bayer

ZiZhu

Novo Nordisk A/S

Huazhong

Gedeon Richter

Actavis

Oral Contraceptive Drugs Segment by Type

Short-acting Contraceptives

Emergency Contraceptives

Long-acting Contraceptives

Oral Contraceptive Drugs Segment by Application

Hospital

Pharmacy

Other

Oral Contraceptive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contraceptive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contraceptive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contraceptive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Contraceptive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Short-acting Contraceptives Table 2. Major Company of Emergency Contraceptives Table 3. Major Company of Long-acting Contraceptives Table 4. Global Oral Contraceptive Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Oral Contraceptive Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Oral Contraceptive Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Oral Contraceptive Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Oral Contraceptive Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Oral Contraceptive Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Oral Contraceptive Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Oral Contraceptive Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Oral Contraceptive Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Oral Contraceptive Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Oral Contraceptive Drugs Industry Trends Table 26. Oral Contraceptive Drugs Industry Drivers Table 27. Oral Contraceptive Drugs Industry Opportunities and Challenges Table 28. Oral Contraceptive Drugs Industry Restraints Table 29. Global Oral Contraceptive Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Oral Contraceptive Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Oral Contraceptive Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Oral Contraceptive Drugs Sales Share by Company (2021-2026) Table 33. Global Oral Contraceptive Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Oral Contraceptive Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Oral Contraceptive Drugs Major Company Production Sites and Headquarters Table 36. Global Oral Contraceptive Drugs Company, Product Type & Application Table 37. Global Oral Contraceptive Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Oral Contraceptive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Oral Contraceptive Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Oral Contraceptive Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Oral Contraceptive Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Oral Contraceptive Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Oral Contraceptive Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Oral Contraceptive Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Oral Contraceptive Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Oral Contraceptive Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Oral Contraceptive Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Oral Contraceptive Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Oral Contraceptive Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Oral Contraceptive Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Oral Contraceptive Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Oral Contraceptive Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Oral Contraceptive Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Oral Contraceptive Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Oral Contraceptive Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Oral Contraceptive Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Oral Contraceptive Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Company Information Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio Table 76. Teva Pharmaceutical Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Oral Contraceptive Drugs Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Baijingyu Company Information Table 83. Baijingyu Business Overview Table 84. Baijingyu Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Baijingyu Oral Contraceptive Drugs Product Portfolio Table 86. Baijingyu Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck Oral Contraceptive Drugs Product Portfolio Table 91. Merck Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Oral Contraceptive Drugs Product Portfolio Table 96. Pfizer Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer Oral Contraceptive Drugs Product Portfolio Table 101. Bayer Recent Development Table 102. ZiZhu Company Information Table 103. ZiZhu Business Overview Table 104. ZiZhu Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. ZiZhu Oral Contraceptive Drugs Product Portfolio Table 106. ZiZhu Recent Development Table 107. Novo Nordisk A/S Company Information Table 108. Novo Nordisk A/S Business Overview Table 109. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio Table 111. Novo Nordisk A/S Recent Development Table 112. Huazhong Company Information Table 113. Huazhong Business Overview Table 114. Huazhong Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Huazhong Oral Contraceptive Drugs Product Portfolio Table 116. Huazhong Recent Development Table 117. Gedeon Richter Company Information Table 118. Gedeon Richter Business Overview Table 119. Gedeon Richter Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Gedeon Richter Oral Contraceptive Drugs Product Portfolio Table 121. Gedeon Richter Recent Development Table 122. Actavis Company Information Table 123. Actavis Business Overview Table 124. Actavis Oral Contraceptive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Actavis Oral Contraceptive Drugs Product Portfolio Table 126. Actavis Recent Development Table 127. North America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 130. North America Oral Contraceptive Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Oral Contraceptive Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Oral Contraceptive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Oral Contraceptive Drugs Market Share by Country (2021-2026) Table 135. North America Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Oral Contraceptive Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Oral Contraceptive Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Oral Contraceptive Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Oral Contraceptive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Oral Contraceptive Drugs Market Share by Country (2021-2026) Table 145. Europe Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Oral Contraceptive Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Oral Contraceptive Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Oral Contraceptive Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Oral Contraceptive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Oral Contraceptive Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Oral Contraceptive Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Oral Contraceptive Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Oral Contraceptive Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Oral Contraceptive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Oral Contraceptive Drugs Market Share by Country (2021-2026) Table 165. Latin America Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Oral Contraceptive Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Oral Contraceptive Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Oral Contraceptive Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Oral Contraceptive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Oral Contraceptive Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Oral Contraceptive Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Oral Contraceptive Drugs Distributors List Table 180. Oral Contraceptive Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Oral Contraceptive Drugs Image Figure 2. Global Oral Contraceptive Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contraceptive Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Contraceptive Drugs Sales (2021-2032) & (K Units) Figure 5. Short-acting Contraceptives Image Figure 6. Global Short-acting Contraceptives Sales YoY Growth (2021-2032) & (K Units) Figure 7. Emergency Contraceptives Image Figure 8. Global Emergency Contraceptives Sales YoY Growth (2021-2032) & (K Units) Figure 9. Long-acting Contraceptives Image Figure 10. Global Long-acting Contraceptives Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Oral Contraceptive Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Oral Contraceptive Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Oral Contraceptive Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Oral Contraceptive Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Oral Contraceptive Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Oral Contraceptive Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Oral Contraceptive Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Oral Contraceptive Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Oral Contraceptive Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Oral Contraceptive Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Oral Contraceptive Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Oral Contraceptive Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Oral Contraceptive Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Oral Contraceptive Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Oral Contraceptive Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Oral Contraceptive Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Oral Contraceptive Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Oral Contraceptive Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Oral Contraceptive Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Oral Contraceptive Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Oral Contraceptive Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Oral Contraceptive Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Oral Contraceptive Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Oral Contraceptive Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Oral Contraceptive Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Oral Contraceptive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Oral Contraceptive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Oral Contraceptive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Oral Contraceptive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Oral Contraceptive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Oral Contraceptive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Oral Contraceptive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Oral Contraceptive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Oral Contraceptive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Oral Contraceptive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Oral Contraceptive Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Oral Contraceptive Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Short-acting Contraceptives
  • Emergency Contraceptives
  • Long-acting Contraceptives
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Baijingyu
  • Merck
  • Pfizer
  • Bayer
  • ZiZhu
  • Novo Nordisk A/S
  • Huazhong
  • Gedeon Richter
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Contraceptive Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Contraceptive Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Contraceptive Drugs Market by Type
  6. 1.3.1 Short-acting Contraceptives
  7. 1.3.2 Emergency Contraceptives
  8. 1.3.3 Long-acting Contraceptives
  9. 1.4 Global Oral Contraceptive Drugs Market Size by Type
  10. 1.4.1 Global Oral Contraceptive Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Oral Contraceptive Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Oral Contraceptive Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Oral Contraceptive Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Oral Contraceptive Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Oral Contraceptive Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Oral Contraceptive Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Oral Contraceptive Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Contraceptive Drugs Industry Trends
  2. 2.2 Oral Contraceptive Drugs Industry Drivers
  3. 2.3 Oral Contraceptive Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Contraceptive Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Contraceptive Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Contraceptive Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Contraceptive Drugs Price (2021-2026)
  4. 3.4 Global Oral Contraceptive Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Contraceptive Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Contraceptive Drugs Company, Product Type & Application
  7. 3.7 Global Oral Contraceptive Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Contraceptive Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Contraceptive Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Contraceptive Drugs Tier 1, Tier 2, and Tier 3
4 Oral Contraceptive Drugs Regional Status and Outlook
  1. 4.1 Global Oral Contraceptive Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Contraceptive Drugs Historic Market Size by Region
  3. 4.2.1 Global Oral Contraceptive Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Contraceptive Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Contraceptive Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Contraceptive Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Oral Contraceptive Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Contraceptive Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Contraceptive Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Contraceptive Drugs by Application
  1. 5.1 Oral Contraceptive Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Oral Contraceptive Drugs Market Size by Application
  6. 5.2.1 Global Oral Contraceptive Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Oral Contraceptive Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Oral Contraceptive Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Oral Contraceptive Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Oral Contraceptive Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Oral Contraceptive Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Oral Contraceptive Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Oral Contraceptive Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Baijingyu
  14. 6.3.1 Baijingyu Company Information
  15. 6.3.2 Baijingyu Business Overview
  16. 6.3.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
  18. 6.3.5 Baijingyu Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Oral Contraceptive Drugs Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Oral Contraceptive Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Oral Contraceptive Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 ZiZhu
  38. 6.7.1 ZiZhu Company Information
  39. 6.7.2 ZiZhu Business Overview
  40. 6.7.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
  42. 6.7.5 ZiZhu Recent Developments
  43. 6.8 Novo Nordisk A/S
  44. 6.8.1 Novo Nordisk A/S Company Information
  45. 6.8.2 Novo Nordisk A/S Business Overview
  46. 6.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
  48. 6.8.5 Novo Nordisk A/S Recent Developments
  49. 6.9 Huazhong
  50. 6.9.1 Huazhong Company Information
  51. 6.9.2 Huazhong Business Overview
  52. 6.9.3 Huazhong Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Huazhong Oral Contraceptive Drugs Product Portfolio
  54. 6.9.5 Huazhong Recent Developments
  55. 6.10 Gedeon Richter
  56. 6.10.1 Gedeon Richter Company Information
  57. 6.10.2 Gedeon Richter Business Overview
  58. 6.10.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
  60. 6.10.5 Gedeon Richter Recent Developments
  61. 6.11 Actavis
  62. 6.11.1 Actavis Company Information
  63. 6.11.2 Actavis Business Overview
  64. 6.11.3 Actavis Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Actavis Oral Contraceptive Drugs Product Portfolio
  66. 6.11.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Oral Contraceptive Drugs Sales by Country
  2. 7.1.1 North America Oral Contraceptive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Contraceptive Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Contraceptive Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Contraceptive Drugs Market Size by Country
  6. 7.2.1 North America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Contraceptive Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Contraceptive Drugs Sales by Country
  2. 8.1.1 Europe Oral Contraceptive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Contraceptive Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Contraceptive Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Contraceptive Drugs Market Size by Country
  6. 8.2.1 Europe Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Contraceptive Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Contraceptive Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Oral Contraceptive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Contraceptive Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Contraceptive Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Contraceptive Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Contraceptive Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Contraceptive Drugs Sales by Country
  2. 10.1.1 South America Oral Contraceptive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Contraceptive Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Contraceptive Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Contraceptive Drugs Market Size by Country
  6. 10.2.1 South America Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Contraceptive Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Contraceptive Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Oral Contraceptive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Contraceptive Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Contraceptive Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Contraceptive Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Contraceptive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Contraceptive Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Contraceptive Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Contraceptive Drugs Value Chain Analysis
  2. 12.1.1 Oral Contraceptive Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Contraceptive Drugs Production Mode & Process
  7. 12.2 Oral Contraceptive Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Contraceptive Drugs Distributors
  10. 12.2.3 Oral Contraceptive Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst